These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms in children with subacute sclerosing panencephalitis. Taşdemir N; Ece A; Tekeş S; Dikici S; Güneş A; Balik H Am J Med Genet B Neuropsychiatr Genet; 2006 Jul; 141B(5):445-8. PubMed ID: 16741935 [TBL] [Abstract][Full Text] [Related]
15. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. Ishizaki Y; Takemoto M; Kira R; Kusuhara K; Torisu H; Sakai Y; Sanefuji M; Yukaya N; Hara T J Neurovirol; 2008 Nov; 14(6):486-91. PubMed ID: 19016379 [TBL] [Abstract][Full Text] [Related]
17. Are SCN1A gene mutations responsible for genetic susceptibility to subacute sclerosing panencephalitis? Garg RK Med Hypotheses; 2012 Feb; 78(2):247-9. PubMed ID: 22098725 [TBL] [Abstract][Full Text] [Related]
18. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG). Enders-Ruckle G Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072 [TBL] [Abstract][Full Text] [Related]
19. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165 [TBL] [Abstract][Full Text] [Related]